NLRP3 and atrial fibrillation: Chronic inflammation leads to immune suppression, which promotes tumor progression, while also facilitating AF through NLRP3 inflammasome activation in atrial cardiomyocytes and via both direct cardiac and systemic effects of pro-inflammatory cytokines such as TNF-α, IL-1, IL-6 and IL-17 [13–15].